TetraLogic Pharmaceuticals Corp. (TLOG) OTC MARKETS
$0 - (-)
Market Cap: $2432
As of 12/13/23 04:00 PM EST. Market open.
TetraLogic Pharmaceuticals Corp. (TLOG)
OTC MARKETS
$0
- (-)
Market Cap: $2432
As of 12/13/23 04:00 PM EST. Market open.
Add to Portfolio
tetralogic pharmaceuticals (nasdaq: tlog) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. we currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester ... read more
tetralogic pharmaceuticals (nasdaq: tlog) is a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. we currently have two clinical-stage product candidates in development: birinapant and suberohydroxamic acid (4-methoxycarbonyl) phenyl ester (shape). read less
COMPANY PROFILE
Sector
Industry
Sector
Industry
Full Time Employees
10
Address
PO Box 1305, Pennsylvania, Paoli, 19301-5305.
PRICE CHART FOR TETRALOGIC PHARMACEUTICALS CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$2432
Dividend Yield
-
P/E
-
Shares Outstanding
24,315,086
Open
-
Previous Close
-
Days Range
- - -
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$2432
Dividend Yield
-
P/E
-
Shares Outstanding
24,315,086
FINANCIAL STATEMENTS FOR TETRALOGIC PHARMACEUTICALS CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR TETRALOGIC PHARMACEUTICALS CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 09, 2016 | Sale | $0.16 | 230,507 | 36,881 | 2,214,523 | Feb 10, 2016, 02:33 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 08, 2016 | Sale | $0.19 | 103,123 | 19,593 | 2,445,030 | Feb 10, 2016, 02:33 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 05, 2016 | Sale | $0.20 | 832,881 | 166,576 | 2,548,153 | Feb 05, 2016, 08:39 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 04, 2016 | Sale | $0.14 | 500,026 | 70,004 | 3,381,034 | Feb 05, 2016, 08:39 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 03, 2016 | Sale | $0.15 | 82,583 | 12,387 | 3,881,060 | Feb 05, 2016, 08:39 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 02, 2016 | Sale | $0.17 | 176,306 | 29,972 | 3,963,643 | Feb 02, 2016, 05:12 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Feb 01, 2016 | Sale | $0.20 | 140,000 | 28,000 | 4,139,949 | Feb 02, 2016, 05:12 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Jan 29, 2016 | Sale | $0.26 | 52,826 | 13,735 | 4,279,949 | Feb 02, 2016, 05:12 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Jan 28, 2016 | Sale | $0.26 | 32,521 | 8,455 | 4,332,775 | Jan 28, 2016, 05:07 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Jan 27, 2016 | Sale | $0.27 | 209,984 | 56,696 | 4,365,296 | Jan 28, 2016, 05:07 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Jan 26, 2016 | Sale | $0.30 | 69,425 | 20,828 | 4,575,280 | Jan 28, 2016, 05:07 PM |
| Pecora Andrew L | Director | Jul 10, 2015 | Buy | $2.68 | 50,000 | 133,944 | 184,830 | Jul 14, 2015, 08:17 AM |
| Pecora Andrew L | Director | Jul 09, 2015 | Buy | $2.40 | 50,000 | 120,090 | 134,830 | Jul 13, 2015, 10:48 AM |
| Schmitt Paul J | Director | Jul 02, 2015 | Buy | $2.34 | 10,000 | 23,357 | 20,000 | Jul 06, 2015, 02:23 PM |
| Meyers Pete A. | CFO & Treasurer | Mar 27, 2015 | Buy | $4.35 | 5,000 | 21,750 | 153,891 | Mar 31, 2015, 07:03 AM |
| BUCHI J KEVIN | President & CEO | Mar 26, 2015 | Buy | $4.23 | 5,000 | 21,147 | 330,714 | Mar 30, 2015, 07:43 AM |
| Begley Colin Glenn | Chief Scientific Officer & SVP | Dec 10, 2014 | Buy | $6.16 | 6,000 | 36,960 | 198,234 | Feb 17, 2015, 03:33 PM |
| BUCHI J KEVIN | President & CEO | Jan 07, 2015 | Buy | $5.04 | 5,000 | 25,181 | 325,714 | Jan 09, 2015, 07:00 AM |
| Begley Colin Glenn | Chief Scientific Officer & SVP | Dec 10, 2014 | Buy | $6.16 | 5,900 | 36,344 | 198,134 | Dec 12, 2014, 06:18 AM |
| BUCHI J KEVIN | President & CEO | Dec 09, 2014 | Buy | $6.01 | 5,000 | 30,060 | 320,714 | Dec 11, 2014, 07:38 AM |
| Meyers Pete A. | CFO & Treasurer | Dec 04, 2014 | Buy | $4.94 | 1,034 | 5,108 | 148,891 | Dec 08, 2014, 07:29 AM |
| BUCHI J KEVIN | President & CEO | Dec 02, 2014 | Buy | $4.99 | 10,000 | 49,900 | 315,714 | Dec 04, 2014, 07:30 AM |
| Begley Colin Glenn | Chief Scientific Officer & SVP | Nov 26, 2014 | Buy | $4.87 | 1,100 | 5,352 | 1,100 | Dec 01, 2014, 11:47 AM |
| Begley Colin Glenn | Chief Scientific Officer & SVP | Nov 26, 2014 | Buy | $4.86 | 2,000 | 9,710 | 192,234 | Dec 01, 2014, 11:47 AM |
| Russell Lesley | Chief Operating Officer | Nov 26, 2014 | Buy | $4.90 | 20,000 | 97,970 | 20,000 | Dec 01, 2014, 09:06 AM |
| Begley Colin Glenn | Chief Scientific Officer & SVP | Nov 25, 2014 | Buy | $4.85 | 2,000 | 9,707 | 190,234 | Nov 28, 2014, 04:43 PM |
| BUCHI J KEVIN | President & CEO | Nov 18, 2014 | Buy | $4.82 | 10,000 | 48,185 | 305,714 | Nov 20, 2014, 08:31 AM |
| Pecora Andrew L | Director | Nov 17, 2014 | Buy | $4.53 | 20,000 | 90,640 | 84,830 | Nov 19, 2014, 12:36 PM |
| Meyers Peter A. | CFO & Treasurer | Nov 12, 2014 | Buy | $3.98 | 5,000 | 19,890 | 147,857 | Nov 13, 2014, 02:20 PM |
| BUCHI J KEVIN | President and CEO | Nov 11, 2014 | Buy | $3.93 | 10,000 | 39,325 | 295,714 | Nov 13, 2014, 07:57 AM |
| Schmitt Paul J | Director | Nov 10, 2014 | Buy | $4.14 | 10,000 | 41,352 | 10,000 | Nov 12, 2014, 12:39 PM |
| Schmitt Paul J | Director | Nov 10, 2014 | Buy | $4.06 | 10,000 | 40,630 | 10,000 | Nov 12, 2014, 12:39 PM |
| Woody James N. | Director | Dec 17, 2013 | Option Exercise | $7.00 | 111,925 | 783,475 | 998,924 | Dec 19, 2013, 02:29 PM |
| Woody James N. | Director | Dec 17, 2013 | Buy | $7.00 | 261,427 | 1,829,989 | 261,427 | Dec 19, 2013, 02:29 PM |
| Woody James N. | Director | Dec 17, 2013 | Option Exercise | $6.40 | 3,064 | 19,616 | 1,001,988 | Dec 19, 2013, 02:29 PM |
| Meyers Peter A. | CFO & Treasurer | Dec 17, 2013 | Buy | $7.00 | 142,857 | 999,999 | 142,857 | Dec 19, 2013, 12:54 PM |
| Schmitt Paul J | Director | Dec 17, 2013 | Option Exercise | $7.00 | 193,863 | 1,357,041 | 1,507,657 | Dec 19, 2013, 12:52 PM |
| Schmitt Paul J | Director | Dec 17, 2013 | Buy | $7.00 | 445,179 | 3,116,253 | 445,179 | Dec 19, 2013, 12:52 PM |
| Schmitt Paul J | Director | Dec 17, 2013 | Option Exercise | $6.40 | 5,305 | 33,964 | 1,512,962 | Dec 19, 2013, 12:52 PM |
| BUCHI J KEVIN | President and CEO | Dec 17, 2013 | Buy | $7.00 | 285,714 | 1,999,998 | 285,714 | Dec 19, 2013, 12:52 PM |
| Pecora Andrew L | Director | Dec 17, 2013 | Option Exercise | $7.00 | 5,887 | 41,209 | 64,669 | Dec 19, 2013, 12:51 PM |
| Pecora Andrew L | Director | Dec 17, 2013 | Buy | $7.00 | 26,551 | 185,857 | 42,727 | Dec 19, 2013, 12:51 PM |
| Pecora Andrew L | Director | Dec 17, 2013 | Option Exercise | $6.40 | 161 | 1,031 | 64,830 | Dec 19, 2013, 12:51 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Dec 17, 2013 | Option Exercise | $7.00 | 853,416 | 5,973,912 | 4,621,423 | Dec 19, 2013, 12:49 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Dec 17, 2013 | Buy | $7.00 | 1,425,063 | 9,975,441 | 1,425,063 | Dec 19, 2013, 12:49 PM |
| Clarus Lifesciences II, L.P. | 10% Owner | Dec 17, 2013 | Option Exercise | $6.40 | 23,282 | 149,056 | 4,644,705 | Dec 19, 2013, 12:49 PM |
| Gavin Brenda D | Director | Dec 17, 2013 | Option Exercise | $7.00 | 48,183 | 337,281 | 948,268 | Dec 19, 2013, 12:48 PM |
| Reed Douglas MD | Director | Dec 17, 2013 | Option Exercise | $7.00 | 278,315 | 1,948,205 | 1,202,152 | Dec 19, 2013, 12:47 PM |
| Reed Douglas MD | Director | Dec 17, 2013 | Buy | $7.00 | 142,857 | 999,999 | 142,857 | Dec 19, 2013, 12:47 PM |
| Reed Douglas MD | Director | Dec 17, 2013 | Option Exercise | $6.40 | 7,590 | 48,593 | 1,209,742 | Dec 19, 2013, 12:47 PM |
| AMGEN INC | 10% Owner | Dec 17, 2013 | Buy | $7.00 | 272,142 | 1,904,994 | 541,399 | Dec 18, 2013, 06:09 PM |
| AMGEN INC | 10% Owner | Dec 17, 2013 | Option Exercise | $6.40 | 1,141 | 7,305 | 269,257 | Dec 18, 2013, 06:09 PM |
| HEALTHCARE VENTURES VII LP | 10% Owner | Dec 17, 2013 | Option Exercise | $6.98 | 274,870 | 1,919,705 | 1,873,003 | Dec 17, 2013, 06:59 PM |
| HEALTHCARE VENTURES VII LP | 10% Owner | Dec 17, 2013 | Buy | $7.00 | 713,463 | 4,994,241 | 2,586,466 | Dec 17, 2013, 06:59 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR TETRALOGIC PHARMACEUTICALS CORP
LOADING...